Around the Net

How Big Pharma Avoids Gov't Price Cuts

"Two years into the pandemic, the [drug] industry has evaded reforms a supermajority of voters want," begins this New York magazine post. Big Pharma is protected partly by an "endless river of money [that] continues to flow, the widest, steadiest current of lobbying largesse the capitol has ever known." That money only hints at "the fullness of Pharma’s influence," which the post further details. 

Read the whole story at New York Magazine »

Next story loading loading..